Lazard Global Equity Franchise Fund A Acc EURRegister to Unlock Ratings |
Performance History | 31/10/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | -2.4 | 22.2 | 7.1 | 12.1 | 1.5 | |
+/-Cat | -16.7 | 7.2 | 17.0 | 2.7 | -5.9 | |
+/-B’mrk | -14.9 | 3.2 | 15.2 | -2.5 | -12.5 | |
Category: Global Flex-Cap Equity | ||||||
Category Benchmark: Morningstar Global All Cap ... |
Key Stats | ||
NAV 20/11/2024 | EUR 162.85 | |
Day Change | -0.17% | |
Morningstar Category™ | Global Flex-Cap Equity | |
ISIN | IE00BYR8PR61 | |
Fund Size (Mil) 20/11/2024 | USD 984.54 | |
Share Class Size (Mil) 20/11/2024 | EUR 2.56 | |
Max Initial Charge | 3.00% | |
Ongoing Charge 25/06/2024 | 0.90% |
Investment Objective: Lazard Global Equity Franchise Fund A Acc EUR |
The investment objective of the Fund is to aim to achieve long-term capital appreciation. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Matthew Landy 30/06/2015 | ||
John Mulquiney 30/06/2015 | ||
Click here to see others | ||
Inception Date 02/04/2019 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI World NR EUR | Morningstar Global All Cap TME NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Lazard Global Equity Franchise Fund A Acc EUR | 31/10/2024 |
|
|
Top 5 Holdings | Sector | % |
Omnicom Group Inc | Communication Services | 7.27 |
Nexi SpA | Technology | 6.93 |
CVS Health Corp | Healthcare | 6.54 |
International Game Technology PLC | Consumer Cyclical | 6.42 |
Rentokil Initial PLC | Industrials | 5.07 |
Increase Decrease New since last portfolio | ||
Lazard Global Equity Franchise Fund A Acc EUR |